Literature DB >> 30851978

Inhibition of macrophage viability by bound and free bisphosphonates.

Somying Patntirapong1, Pawinee Phupunporn2, Daranee Vanichtantiphong2, Watcharawee Thanetchaloempong2.   

Abstract

INTRODUCTION: Long-term administration of bisphosphonates (BPs) may cause osteonecrosis of the jaw (BRONJ). After administration, 50% of BPs in the circulation rapidly binds to calcium phosphate of bone. Two forms, bound and free BPs, may affect cells residing in bone including macrophages. Therefore, the aim of this study was to examine the effects of bound and free BPs on macrophage viability.
MATERIALS AND METHODS: Biomaterials coated with BPs were used as a model to investigate the effect of bound BPs. For free BPs, RAW cells were plated on uncoated materials and BPs were added into the media. Cell viability and number were investigated by MTT assay and nuclei staining, respectively. Furthermore, coating and washing media were collected and were used to examine cell viability.
RESULTS: RAW cells grew on biomaterials for 7 days. At 3 days, free and calcium-bound BPs significantly decreased cell viability and cell number compared to control. Coating media collected from pre-incubation with BP-coated composite materials reduced macrophage cell viability.
CONCLUSION: This study showed that macrophages were directly affected by bound and free BPs. The presence of macrophages is mandatory for bone healing, thus the inhibition of cell viability might serve as an etiology of BRONJ.
Copyright © 2019 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Bisphosphonate; Bound; Free; Macrophage; Viability

Mesh:

Substances:

Year:  2019        PMID: 30851978     DOI: 10.1016/j.acthis.2019.02.007

Source DB:  PubMed          Journal:  Acta Histochem        ISSN: 0065-1281            Impact factor:   2.479


  5 in total

1.  Duration and timing of bisphosphonate treatment as factors determining osteoblast mineralization.

Authors:  Somying Patntirapong
Journal:  J Oral Biol Craniofac Res       Date:  2022-07-31

Review 2.  Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review.

Authors:  Ioannis Gkouveris; Akrivoula Soundia; Panagiotis Gouveris; Dionysia Zouki; Danny Hadaya; Sotirios Tetradis
Journal:  Cancers (Basel)       Date:  2022-01-10       Impact factor: 6.575

3.  Zoledronate Causes a Systemic Shift of Macrophage Polarization towards M1 In Vivo.

Authors:  Manuel Weber; Andi Homm; Stefan Müller; Silke Frey; Kerstin Amann; Jutta Ries; Carol Geppert; Raimund Preidl; Tobias Möst; Peer W Kämmerer; Marco Kesting; Falk Wehrhan
Journal:  Int J Mol Sci       Date:  2021-01-28       Impact factor: 5.923

4.  Characterization of Mesenchymal Stem Cells Derived from Bisphosphonate-Related Osteonecrosis of the Jaw Patients' Gingiva.

Authors:  Mengyu Li; Jiajia Wang; Yejia Yu; Yuqiong Zhou; Yueqi Shi; Wenjie Zhang; Geehun Son; Jing Ge; Jun Zhao; Chi Yang; Shaoyi Wang
Journal:  Stem Cell Rev Rep       Date:  2021-09-22       Impact factor: 5.739

5.  An Approach for the Prevention, Diagnosis, and Treatment of Jaw Osteonecrosis: Report of a Case Associated with Zoledronic Acid.

Authors:  Danila S de Alexandria Santos; Marco Vinícius de Sales Lima; Alexandre do Prado Scherma; Dárcio Kitakawa; Natália de Castro Magalhães; Felipe da Silva Peralta; Luis Felipe das Chagas E Silva de Carvalho
Journal:  Am J Case Rep       Date:  2020-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.